SightfileU.S. market data from official filings

Citius Pharmaceuticals Inc (CTXR)

Name: Citius Pharmaceuticals Inc (CTXR) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001506251 · EDGAR filings · Updated 2026-06-04

Citius Pharmaceuticals Inc (CTXR) has reported institutional ownership of 3.6%, with 37 institutional managers holding positions valued at $896.0K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

3.6%

Institutional managers

Reported 13F value

$896.0K

Data flags

2 active

from SEC filings

Latest updates

2026-06-04 — SCHEDULE 13D/A filed
2026-06-02 — EFFECT filed
2026-06-01 — Current report (8-K) filed
2026-05-22 — Shelf registration (S-3) filed
2026-05-15 — Current report (8-K) filed
2026-05-15 — Quarterly report (10-Q) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Citius Pharmaceuticals Inc has 37 institutional holders and institutional ownership of 3.6%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2020-02-13) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-02-13 (recurring since 2020-02-03) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Beyond Air Inc (XAIR) · SEASTAR MEDICAL HOLDING CORP (ICU) · BIOAFFINITY TECHNOLOGIES INC (BIAF) · BULLFROG AI HLDGS INC (BFRG) · Tempest Therapeutics Inc (TPST) · BioCardia Inc (BCDA)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-04.